Endogenex

Plymouth, MN · Founded 2017 · Privately Held (backing)

Developer of a medical device system designed to improve metabolic function in individuals with diabetes by resetting metabolic signalling in the small intestine. Endogenex is based in Plymouth, MN and was founded in 2017. It was valued at $218 million at its later-stage round in Mar 2026, the last priced event on record. It has raised $190 million across 3 recorded rounds; the latest was a $69.6 million later-stage round in Jun 2024.

PMV mark · valuation
$218.0M
Oct 2026
Priced at
its later-stage round
Mar 2026
Total raised
$190.4M
Last round
Later Stage VC
Jun 2024
How much has Endogenex raised?
$190.4Macross 3 recorded rounds · Feb 2023 – Jun 2024

Most recently, Endogenex raised $69.6M in its Later Stage VC (Jun 2024).

Free account
More of Endogenex with a free account
  • ·The complete investor list: 11 names
  • ·Watch Endogenex: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Endogenex round by round

3 rounds
Jun 2024Later Stage VC$69.6MSEC filing▮
11 investors participated
Oct 2023Early Stage VC$18.3MSEC filing▮
9 investors participated
Feb 2023Early Stage VC$9.2MSEC filing▮
7 investors participated

How much has Endogenex raised?

Endogenex has raised $190 million across 3 recorded rounds since 2023. The largest was a $9.2 million early-stage round in Feb 2023; the most recent was a $69.6 million later-stage round in Jun 2024.

Endogenex has filed 3 Form Ds with the SEC since 2023, most recently in Jun 2024 ($69.6 million sold to 11 investors).

Endogenex investors

11 investors are on record for Endogenex, including Hatteras Venture Partners, Mayo Clinic Ventures, Arboretum Ventures and Longitude Capital. The later-stage round in Jun 2024 drew 11 investors.

For fundraisers
Raising for a company like Endogenex?

11 investors have backed Endogenex.

See all 11 investors →

Frequently asked about Endogenex

How much has Endogenex raised?
Endogenex has raised $190.4M in total across 3 recorded funding rounds.
When was Endogenex's last funding round?
Endogenex's most recent recorded round was Later Stage VC in Jun 2024, raising $69.6M.